2007

What should our blood pressure goal be in patients with diabetes?
Cushman WC. J Clin Hypertens (Greenwich).2007 Nov;9(11):823-6.

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
ADVANCE Collaborative Group - Lancet. 2007 Sep 8;370(9590):829-40.
Abstract

Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus.
Stolk RP, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Juming L, Patel A, Thom SA, Grobbee DE; AdRem project team and ADVANCE management committee.
Contemp Clin Trials. 2007 Jan;28(1):6-17. Epub 2006 Sep 3.
Abstract

2006

ADVANCE: Lessons from the run-in phase of a large study in type 2 diabetes.
ADVANCE Collaborative Group.
Blood Pressure. 2006;15:340-346.

ADVANCE: breaking new ground in type 2 diabetes.
Chalmers J, Perkovic V, Joshi R, Patel A.
J Hypertens Suppl. 2006 Aug;24(5):S22-8.
Abstract

2005

ADVANCE: action in diabetes and vascular disease.
Patel A, Chalmers J, Poulter N.
J Hum Hypertens. 2005 Jun;19 Suppl 1:S27-32. Review.
Abstract

ADVANCE--Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline.
ADVANCE Collaborative Group.
Diabet Med. 2005 Jul;22(7):882-8.
Abstract

2004

"Nouvelles stratégies pour le contrôle de l’hypertension: preuves supplémentaries en faveur des associations faiblement dosées. (New Strategies for hypertension control : more evidence for low-dose combination therapy)."
Chalmers, J. Am J Cardiovasc Drugs 4(Suppl 1): 37-42.

2003

How to ADVANCE prevention of cardiovascular complications in type 2 diabetes.
Grobbee DE.
Metabolism. 2003 Aug;52(8 Suppl 1):24-8. Review.
Abstract

Diabetes and vascular disease: a new international trial.
Patel A, Chalmers J, Chaturvedi V, Currie R, Monaghan H, Neal B.
Asian Cardiovasc Thorac Ann. 2003 Jun;11(2):180-4. Review.
Abstract

[ADVANCE study: objectives, design and current status].
Chalmers J.
Drugs. 2003;63 Spec No 1:39-44. French.
Abstract

2001

Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus. Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation.
[No authors listed]
J Hypertens Suppl. 2001 Nov;19(4):S21-8.
Abstract

Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation.
[No authors listed]
Diabetologia. 2001 Sep;44(9):1118-20.
Abstract

Blood pressure lowering in diabetes: a brief review of the current evidence and description of a new trial.
Patel A, Chalmers J, Neal B, Chapman N, Girgis S, MacMahon S.
Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1108-11.
Abstract